Post by Novartis Medical
5,266 followers
This #EAACICongress2026 we’re exploring treatment approaches in chronic spontaneous urticaria (CSU). Want to be part of the conversation? In the video below, Profs Torsten Zuberbier and Philip Li are discussing real-world management of CSU, from current treatments to newer options that may change the trajectory of patient care. And that's just the start... Keep the conversation going on our booth or at https://lnkd.in/ejYKxgSt This non-promotional activity is created and funded by Novartis Pharma AG, for HCPs only. Content not intended for a UK audience.
Video Content